C07D 203/26
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D203/26 (Condensed with carbocyclic rings or ring systems) appears on 46 US grants and 33 published applications in this corpus.
Search patents in C07D- Granted patents
- 46
- Published applications
- 33
- Assignees
- 42
- Inventors
- 137
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 3 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 4 |
| 2003 | 1 | 0 |
| 2004 | 2 | 2 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 1 | 2 |
| 2010 | 3 | 3 |
| 2011 | 3 | 3 |
| 2012 | 2 | 4 |
| 2013 | 1 | 2 |
| 2014 | 1 | 1 |
| 2015 | 4 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of 8,9-dihydrocannabidiol compounds19 May 2026US 12,629,384 B2The Regents of the University of California
- Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same6 Feb 2024US 11,891,655 B2Battelle Memorial Institute
- Conduritol aziridine derivatives and uses thereof28 Nov 2023US 11,826,435 B2University of Saskatchewan
- Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same31 May 2022US 11,345,950 B2Battelle Memorial Institute
- Antiviral agents against HBV infection10 Apr 2018US 9,938,236 B2Arbutus Biopharma Corporation
- Bicyclic heterocycles and their ligands for targeted delivery of therapeutic agents3 Jul 2025US 2025/0213698 A1Hansoh Bio LLC
- Use of 8,9- dihydrocannabidiol compounds15 May 2025US 2025/0152520 A2The Regents of the University of California
- Probe for selectively characterizing enzymes involved in xenobiotic metabolism and method of making and using the same8 Sep 2022US 2022/0282317 A1Battelle Memorial Institute
- Use of 8,9- dihydrocannabidiol compounds16 Jun 2022US 2022/0183998 A1The Regents of the University of California
- Conduritol aziridine derivatives and uses thereof25 Feb 2021US 2021/0052752 A1University of Saskatchewan
Most cited
By later US patents
- 2-Aminocycloaliphatic amide compounds92US 4,145,435 AThe Upjohn Company · 1979
- N-acylsulfonamide apoptosis promoters54US 6,720,338 B2Abbott Laboratories · 2004
- N-acylsulfonamide apoptosis promoters43US 7,504,512 B2Abbott Laboratories · 2009
- Compounds and methods for synthesis and therapy39US 6,111,132 AGilead Sciences, Inc. · 2000
- N-acylsulfonamide apoptosis promoters29US 7,754,886 B2Abbott Laboratories · 2010